Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 174Leukemia 163Lymphoma 148Lymphoma, Non-Hodgkin 142Leukemia, Myeloid, Acute 142Myelodysplastic Syndromes 132Hodgkin Disease 123Lymphoma, Follicular 111Lymphoma, Mantle-Cell 108Multiple Myeloma 105Lymphoma, Large B-Cell, Diffuse 96Lymphoma, B-Cell, Marginal Zone 89Burkitt Lymphoma 85Myeloproliferative Disorders 73Leukemia, Myelomonocytic, Chronic 63Congenital Abnormalities 63Leukemia, Myeloid, Chronic-Phase 62Lymphoma, Large-Cell, Immunoblastic 61Leukemia, Myeloid, Accelerated Phase 60Waldenstrom Macroglobulinemia 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 53Neoplasms, Plasma Cell 52Primary Myelofibrosis 48Recurrence 46Blast Crisis 44Anemia, Refractory, with Excess of Blasts 43Lymphoma, T-Cell, Cutaneous 42Dendritic Cell Sarcoma, Interdigitating 42Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 40

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × fludarabine phosphate × Lymphoid × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡